TNF-α in Combination with Palmitate Enhances IL-8 Production via The MyD88-Independent TLR4 Signaling Pathway: Potential Relevance to Metabolic Inflammation

Elevated levels of IL-8 (CXCL8) in obesity have been linked with insulin resistance and type 2 diabetes (T2D). The mechanisms that lead to the profound production of IL-8 in obesity remains to be understood. TNF-alpha and saturated free fatty acids (FFAs) are increased in obese humans and correlate with insulin resistance. Hence, we sought to investigate whether the cooccurrence of TNF-alpha and FFAs led to increase the production of IL-8 by human monocytes. We found that co-stimulation of human monocytes with palmitate and TNF-alpha led to increased IL-8 production as compared to those stimulated with palmitate or TNF-alpha alone. The synergistic production of IL-8 by TNF-alpha /palmitate was suppressed by neutralizing anti- Toll like receptor 4 (TLR4) antibody and by genetic silencing of TLR4. Both MyD88-deficient and MyD88-competent cells responded comparably to TNF-alpha /Palmitate. However, TIR-domain-containing adapter-inducing interferon (TRIF) inhibition or interferon regulatory transcription factor 3 (IRF3) knockdown partly blocked the synergistic production of IL-8. Our human data show that increased adipose tissue TNF-alpha expression correlated positively with IL-8 expression (r = 0.49, P = 0.001). IL-8 and TNF-alpha correlated positively with macrophage markers including CD68, CD163 and CD86 in adipose tissue. These findings suggest that the signaling cross-talk between saturated fatty acid palmitate and TNF-alpha may be a key driver in obesity-associated chronic inflammation via an excessive production of IL-8.